Wu Changzheng, president of Wenzheng College of Soochow University. [Photo provided to China Daily]
Wong Yuk-shan, president of the Open University of Hong Kong, said the fifth plenary session will usher in a series of important national measures for the next 15 years leading to 2035. "So Hong Kong should definitely not let these rare opportunities pass by," he said.
With this high-speed in vivo drug screening system combined with machine learning, Shi said that a shortcut is provided to help identify compounds with significantly higher therapeutic potentials for further development, hence speed up the drug development and reduce the failure rate in the process.
Wood-carving masters in Southwest China's Chongqing recently used a whole piece of Chinese ebony to showcase the beauty of the Great Wall of China. The wood work is 5.6 meters long and weighs about 1.4 tons.
Within 12 hours, the first team of 121 medical workers from six hospitals in Beijing, including 21 from Peking Union Medical College Hospital, arrived in Wuhan, and devoted themselves to the fight against the pandemic.
Wu Yibing, head of China unit at Temasek, a Singapore state investor, said the ongoing registration-based reform has created "huge opportunities" for global investors, while there is large potential for foreign asset managers to increase their holdings of Chinese assets.
苏州关键词seo排名
Wood described the book as “very important” and said it “introduces a significant dramatic form which is completely unknown in the West, though most tourists who visit China will be familiar with Peking Opera. Pingju is so much more”.
Workers from across all areas, from medical and education to logistics and local communities, fulfill critical tasks every day that support society and benefit our lives. This year, we're saluting their efforts in a series of posters to mark Labor Day on May 1.
Women ride bicycles of bike-sharing startup HelloChuxing in Shenyang, Liaoning province. [Photo/VCG]
Wu Xin, managing director of UCB China, said about five innovative molecules, including those treating autoimmune disease and osteoporosis, are scheduled by the company to be launched in the China market over the next five years.